Results

Total Results: 744 records

Showing results for "presence".

1. Transparency of Reporting Requirements: Management of Infertility (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
   September 02, 2016 - strategy vary by patient characteristics such as age, ovarian reserve, race, body mass index (BMI), presence … of other potential causes of female infertility, or presence of male factor infertility? … of other potential causes of female infertility, or presence of male factor infertility? … of other potential causes of female infertility, or presence of male factor infertility? … of other potential causes of female infertility, or presence of male factor infertility?

2. The Performance of Fusion Procedures for Degenerative Disease of teh Lumbar Spine (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-protocol.pdf
   June 20, 2024 - , presence and type of concomitant degenerative lumbar spine disease, and degree (grade, severity) of … Special populations and factors for Key Questions 5 and 6: Age, sex, BMI, presence of psychological … comorbidities, presence of medical comorbidities, baseline pain severity, presence and type of concomitant … degenerative lumbar spine disease, presence and severity of DLS. … of radiculopathy, neurogenic claudication), degree/grade of DLS, presence of psychological and medical

3. Untitled (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
   October 12, 2015 - of other potential causes of female infertility, or presence of male factor infertility? … Presence of gestational sac !! Positive fetal heart rate o! Pregnancy complications !! … of endometriomia (ovarian cyst with endometrial tissue); and presence 7! … presence!or!absence!of!male!factor!infertility,!presence!of! endometrioma,!other!female!causes!of! … presence!or!absence!of! Individuals! younger!than!18! or!45!and!older! 13!

4. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
   April 01, 2010 - VA hospital), the patient populations they serve, and the presence of a strong hospital-wide palliative … If a cancer patient has a cancer-related outpatient visit then there should be screening for the presence … pain score IF a cancer patient is admitted to a hospital then there should be screening for the presence … cancer patient is newly diagnosed with advanced cancer, then there should be an assessment of the presence … of fatigue If a patient with cancer is found to have anemia with a hemoglobin <10 g/dl, then the presence

5. Alcohol-Misuse-Drug-Therapy Clinician (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
   February 01, 2016 - The DSM-5 uses 11 criteria to define AUD (see Appendix 1 on page 3), the presence of 2 of which indicates … Appendix 1: Criteria Used To Define AUD in the DSM-5 (2013)** ** The presence of at least 2 of the … The severity of the AUD is defined as follows: mild = the presence of two to three symptoms; moderate … = the presence of four to five symptoms; severe = the presence of six or more symptoms.

6. Renal-Function Research-Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
   June 13, 2013 - Presence of baseline or prior elevated troponins g. Presence of ischemic EKG changes h. … Presence of baseline or prior elevated troponins g. Presence of ischemic EKG changes h. … Presence of baseline or prior elevated troponins g. Presence of ischemic EKG changes h. … Presence of baseline or prior elevated troponins g. Presence of ischemic EKG changes h. … of baseline or prior elevated troponins, presence of ischemic EKG changes (for patients with suspected

7. Disposition of Comments Report for Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_disposition-comments.pdf
   January 01, 2011 - RPA recommends the report be very clear about whether any diagnostic test is to be used to predict presence … or absence of bone marrow iron versus presence or absence of a clinically meaningful response to IV … Studies that investigated diagnostic test is to be used to predict presence or absence of bone marrow … Need to be very clear about whether any diagnostic test is used to predict presence or absence of bone … marrow iron vs. presence or absence of a clinically meaningful response to IV iron supplementation

8. Translation of a C. difficile Treatment Clinical Pathway Into Machine-Readable Clinical Decision Support Artifacts Prototyped for Electronic Health Record Implementation (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
   November 01, 2019 - ] in Stool LOINC 2.66 13957-6 Clostridioides difficile toxin A [Presence] in Stool by Immunoassay … ] in Stool by Agglutination LOINC 2.66 20762-1 Clostridioides difficile [Presence] in Stool by Aerobe … ] in Stool by Immunoassay LOINC 2.66 34712-0 Clostridioides difficile [Presence] in Stool LOINC … ] in Stool by NAA with probe detection LOINC 2.66 562-9 Clostridioides difficile [Presence] in Stool … by Organism specific culture LOINC 2.66 563-7 Clostridioides difficile [Presence] in Unspecified

9. Atrial-Fibrillation-Ablation Surveillance (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
   May 16, 2013 - the presence of heart disease as a significant predictor of AF recurrence. 1 signal (other). … of chronic kidney disease,12 presence of metabolic syndrome5 were associated with higher AF recurrence … of heart disease was shown as a significant predictor of AF recurrence: HR (presence of CHF) … =10.903, 95% CI: 2.602, 45.6949 HR (absence of CAD)=0.58, 95% CI: 0.36, 0.9410 OR (presence … of CKD,12 presence of metabolic syndrome5 Increased levels of AFCL9 and NA

10. Pharmacologic Management of Acute Pain by EMS in the Prehospital Setting Protocol Amendment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-ems-protocol-amendment.pdf
    January 28, 2019 - Outcomes: • KQ 1,3: o Pain severity scores and presence of pain, as defined by the tools and thresholds … Outcomes KQ 1 and 3: Pain severity scores, presence of pain, time to analgesic effect, dissociative … To assess for the presence of publication bias, visual inspection of funnel plots will be considered … The outcomes that were prioritized for grading include pain severity, presence of pain, time to analgesic … graded outcomes Outcome Clinically important difference Pain score 2 points on a continuous scale Presence

11. Metzger (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/metzger.pdf
    January 01, 2010 - of Web 2.0 to Engage Community Intelligence for Patient-­‐Centered Research • Establish a Web 2.0 presence

12. Executive Summary_The Effect of Protein Intake on Health: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-executive-summary.pdf
    November 01, 2024 - However, these markers may not fully represent the conditions’ presence and progression. … intermediate markers for bone and kidney disease and sarcopenia, which may not fully reflect the presence

13. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
    December 01, 2011 - , ejection fraction, primary or rescue PCI, use of glycoprotein IIb/IIIa inhibitors, ischemia time, presence … , ejection fraction, primary or rescue PCI, use of glycoprotein IIb/IIIa inhibitors, ischemia time, presence … ejection fraction, primary or rescue PCI, use of glycoprotein IIb/IIIa- inhibitors, ischemia time, presence … Egger’s weighted regression statistic was used to assess for the presence of publication bias.9 Statistics … Q statistic: A test to assess the presence of statistical heterogeneity among several studies.

14. Dyspnea DEcIDE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea_research.pdf
    April 01, 2010 - A simple question into the presence or absence of dyspnea would be unlikely to help guide therapy, as … These assessments may have included dichotomous identification (yes/no) for the presence of dyspnea, … routine assessment of underlying causes,10 a Japanese end-of-life indicator for assessment of the presence … Inquiry into only the presence or absence of dyspnea is unlikely to help guide therapy as complete relief … organizational and operational aspects of the healthcare delivery system (an example would be the presence

15. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
    September 01, 2011 - smoking status, obesity status, severity of GERD symptoms, type of and response to previous medication, presence … and severity of esophagitis, presence and size of hiatal hernia, presence of esophageal motility abnormality … , and (among patients off medication) presence of abnormal esophageal acidification. … Eight cohort studies demonstrated that obesity, presence of baseline typical GERD symptoms, and more … - Obesity, presence of baseline typical GERD symptoms, and more severe esophagitis were significantly

16. S13 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
    October 01, 2007 - clinical research, in general, is to differen- tiate between the absence of an association and the presence … Indi- rect associations occur because of confounding, which happens when the presence of a variable other … decision to continue or discontinue the drug, is based on a patient’s blood pressure response and the presence

17. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0129_07-13-2009.pdf
    January 01, 2009 - delivery and no prior cesarean delivery Intervention(s): consultation/prenatal care with a midwife; presence

18. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
    December 31, 2022 - characteristics (e.g., age, gender, race/ethnicity, and comorbidities), COVID- 19 disease severity, presence … the risk of reinfection vary by factors such as initial antibody levels, patient characteristics, presence … patient characteristics, case identification method (e.g., surveillance, symptomatic testing only), presence … Another important question is whether the presence of antibodies is itself the mechanism of protection … characteristics (e.g., age, gender, race/ethnicity, and comorbidities), COVID-19 disease severity, presence

19. Slide 1
    effectivehealthcare.ahrq.gov/sites/default/files/sensitivity-analysis-chapter-11.pptx
    January 01, 2013 - The sensitivity of an association to the presence of a confounder can result in more nuanced inferences … The robustness of an association to the presence of a confounder can alter inferences that might be drawn … can build confidence in applying the results uniformly to all subpopulations and may highlight the presence … These distributions are best modeled as two parts: (1) as a dichotomous variable to determine the presence

20. Febrile-Infants-Diagnosis-Management Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
    March 01, 2012 - The presence of SBI was determined by confirming bacterial growth in blood, CSF, stool, and/or urine … These criteria were the following: temperature ≥ 40°C,30,35,36 ill appearance (i.e., presence of at … The sensitivity of UA (dipstick; the presence of LE or nitrite, or both) for identifying infants with … The reported data on the presence of HSV in febrile infants 3 months or younger was scarce. … What is the evidence that the presence of an identified viral infection predicts against a serious